Here's a recap of the week’s most important stories.

A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to ...

PGIM has decided not to rush a replacement for Adler’s role but to wait until the CEO transition is complete, with Hunt overseeing the alternatives business in the meantime. PGIM’s topnotch ...